BASES FISIOPATOLÓGICAS Y TERAPEÚTICAS EN ENFERMEDADES AUTOINMUNES
BAFITEA
![Foto de BASES FISIOPATOLÓGICAS Y TERAPEÚTICAS EN ENFERMEDADES AUTOINMUNES](/img/grupo.png)
![Foto de Hospital Universitario Virgen de la Victoria](/img/noimage_org.png)
Hospital Universitario Virgen de la Victoria
Málaga, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen de la Victoria (32)
2022
-
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
npj Genomic Medicine, Vol. 7, Núm. 1
2020
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
2019
-
Digital ischaemia and HCV, a vasculitis of uncertain aetiology
BMJ Case Reports
-
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
Nature Communications, Vol. 10, Núm. 1
2016
-
LILRA3 deficiency is not involved in the giant cell arteritis and systemic sclerosis predisposition
Clinical and Experimental Rheumatology
2015
-
Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis
Clinical and Experimental Rheumatology, Vol. 33, pp. 31-35
2014
-
A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility
Arthritis Research and Therapy, Vol. 16, Núm. 1
2013
-
A case-control study suggests that the CCR6 locus is not involved in the susceptibility to giant cell arteritis
Clinical and Experimental Rheumatology, Vol. 31, Núm. SUPPL.75
-
Evidence of association of the NLRP1 gene with giant cell arteritis
Annals of the Rheumatic Diseases
-
Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility
Annals of the Rheumatic Diseases, Vol. 72, Núm. 7, pp. 1233-1238
-
Influence of the STAT3 genetic variants in the susceptibility to psoriatic arthritis and Behcet's disease
Human Immunology, Vol. 74, Núm. 2, pp. 230-233
2012
-
Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis
Arthritis Research and Therapy, Vol. 14, Núm. 3
-
Autoimmune disease-associated CD226 gene variants are not involved in giant cell arteritis susceptibility in the Spanish population
Clinical and Experimental Rheumatology, Vol. 30, Núm. SUPPL. 70
-
Evaluation of a shared autoimmune disease-associated polymorphism of TRAF6 in systemic sclerosis and giant cell arteritis
Journal of Rheumatology, Vol. 39, Núm. 6, pp. 1275-1279
-
Influence of the IL6 gene in susceptibility to systemic sclerosis
Journal of Rheumatology, Vol. 39, Núm. 12, pp. 2294-2302
-
The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis
Genes and Immunity, Vol. 13, Núm. 2, pp. 191-196
2011
-
A nonsynonymous functional variant of the ITGAM gene is not involved in biopsy-proven giant cell arteritis
Journal of Rheumatology, Vol. 38, Núm. 12, pp. 2598-2601
-
A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort
Annals of the Rheumatic Diseases, Vol. 70, Núm. 4, pp. 638-641
-
No evidence for association between the CCR5/Delta32CCR5 polymorphism and systemic sclerosis
Clinical and Experimental Rheumatology
2010
-
The TRAF1-C5 region on chromosome 9q33 is associated with multiple autoimmune diseases
Annals of the Rheumatic Diseases, Vol. 69, Núm. 4, pp. 696-699